253 related articles for article (PubMed ID: 7753783)
1. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.
Mahfoudi A; Roulet E; Dauvois S; Parker MG; Wahli W
Proc Natl Acad Sci U S A; 1995 May; 92(10):4206-10. PubMed ID: 7753783
[TBL] [Abstract][Full Text] [Related]
2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogens activate an estrogen receptor mutant exhibiting enhanced binding to the estrogen response element.
Xing H; Haase S; Shapiro DJ
Biochem Biophys Res Commun; 1994 Jul; 202(2):888-95. PubMed ID: 8048961
[TBL] [Abstract][Full Text] [Related]
4. Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor.
Zajchowski DA; Webster L; Humm R; White FA; Simmons SJ; Bartholdi M
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):373-83. PubMed ID: 9449240
[TBL] [Abstract][Full Text] [Related]
5. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
6. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
Montano MM; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
[TBL] [Abstract][Full Text] [Related]
7. Interaction of proteins with transcriptionally active estrogen receptors.
Cavaillès V; Dauvois S; Danielian PS; Parker MG
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10009-13. PubMed ID: 7937828
[TBL] [Abstract][Full Text] [Related]
8. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
Métivier R; Penot G; Flouriot G; Pakdel F
Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
[TBL] [Abstract][Full Text] [Related]
9. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
Huang HJ; Norris JD; McDonnell DP
Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
[TBL] [Abstract][Full Text] [Related]
10. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
11. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
Catherino WH; Wolf DM; Jordan VC
Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979
[TBL] [Abstract][Full Text] [Related]
12. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.
McInerney EM; Tsai MJ; O'Malley BW; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10069-73. PubMed ID: 8816752
[TBL] [Abstract][Full Text] [Related]
13. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
Katzenellenbogen BS; Fang H; Ince BA; Pakdel F; Reese JC; Wooge CH; Wrenn CK
Breast Cancer Res Treat; 1993; 27(1-2):17-26. PubMed ID: 8260727
[TBL] [Abstract][Full Text] [Related]
14. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
Hall JM; McDonnell DP
Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
[TBL] [Abstract][Full Text] [Related]
15. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region.
Ali S; Metzger D; Bornert JM; Chambon P
EMBO J; 1993 Mar; 12(3):1153-60. PubMed ID: 8458328
[TBL] [Abstract][Full Text] [Related]
16. Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12.
Pearce ST; Liu H; Jordan VC
J Biol Chem; 2003 Feb; 278(9):7630-8. PubMed ID: 12496244
[TBL] [Abstract][Full Text] [Related]
17. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.
McDonnell DP; Clemm DL; Hermann T; Goldman ME; Pike JW
Mol Endocrinol; 1995 Jun; 9(6):659-69. PubMed ID: 8592512
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens.
Drewes T; Clairmont A; Klein-Hitpass L; Ryffel GU
Eur J Biochem; 1994 Oct; 225(1):441-8. PubMed ID: 7925467
[TBL] [Abstract][Full Text] [Related]
19. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
20. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]